An Umbrella Review of Effectiveness of Intravenous Ketamine in Treatment-Resistant Depression

被引：0
|
作者：
Klassen, A. M. [1 ]
Baten, C. [1 ]
Shepherd, J. H. [1 ]
Zamora, G. [1 ]
Johnson-Venegas, E. [1 ]
Madugula, S. S. [2 ]
Woo, E. [1 ]
Miller, J. A. [3 ]
Sacchet, M. D. [4 ]
Hedges, D. W. [5 ]
Miller, C. H. [1 ]
机构：
[1] Calif State Univ Fresno, Dept Psychol, Fresno, CA 93740 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Palo Alto Univ, Dept Psychol, Palo Alto, CA USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA
[5] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
O0099
引用
收藏
页码：S86 / S87
页数：2
相关论文
共 50 条
  • [21] Effects of Repeated Intravenous Ketamine in Treatment-Resistant Geriatric Depression A Case Series
    Bryant, Kelly A.
    Altinay, Murat
    Finnegan, Nora
    Cromer, Kim
    Dale, Roman M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (02) : 158 - 161
  • [22] Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
    Price, Rebecca B.
    Nock, Matthew K.
    Charney, Dennis S.
    Mathew, Sanjay J.
    BIOLOGICAL PSYCHIATRY, 2009, 66 (05) : 522 - 526
  • [23] Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
    aan het Rot, Marije
    Collins, Katherine A.
    Murrough, James W.
    Perez, Andrew M.
    Reich, David L.
    Charney, Dennis S.
    Mathew, Sanjay J.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (02) : 139 - 145
  • [24] Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study
    Wlodarczyk, Adam
    Cubala, Wieslaw J.
    Galuszko-Wegielnik, Maria
    Szarmach, Joanna
    MEDICINE, 2021, 100 (29) : E26769
  • [25] Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study
    Cullen, Kathryn R.
    Amatya, Palistha
    Roback, Mark G.
    Albott, Christina Sophia
    Schreiner, Melinda Westlund
    Ren, Yanan
    Eberly, Lynn E.
    Carstedt, Patricia
    Samikoglu, Ali
    Gunlicks-Stoessel, Meredith
    Reigstad, Kristina
    Horek, Nathan
    Tye, Susannah
    Lim, Kelvin O.
    Klimes-Dougan, Bonnie
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (07) : 437 - 444
  • [26] Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
    Chisamore, Noah
    Danayan, Kevork
    Rodrigues, Nelson B.
    Di Vincenzo, Joshua D.
    Meshkat, Shakila
    Doyle, Zoe
    Mansur, Rodrigo
    Phan, Lee
    Fancy, Farhan
    Chau, Edmond
    Tabassum, Aniqa
    Kratiuk, Kevin
    Arekapudi, Anil
    McIntyre, Roger S.
    Rosenblat, Joshua D.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (08) : 775 - 783
  • [27] The effectiveness of repeated intravenous ketamine on subjective and objective psychosocial function in patients with treatment-resistant depression and suicidal ideation
    Zhou, Yanling
    Wang, Chengyu
    Lan, Xiaofeng
    Zheng, Wei
    Li, Hanqiu
    Chao, Ziyuan
    McIntyre, Roger S.
    Ning, Yuping
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 304 : 78 - 84
  • [28] The use of subcutaneous ketamine for treatment-resistant depression
    Vargas Alves Nunes, A.
    Carrara, E.
    Odebrecht Vargas Nunes, S.
    Fernandes Jorge, I.
    Alves, E.
    Haddad, M.
    EUROPEAN PSYCHIATRY, 2019, 56 : S95 - S95
  • [29] Feasibility of continuation ketamine for treatment-resistant depression
    aan het Rot, Marije
    Mathew, Sanjay J.
    Collins, Katherine A.
    Perez, Andrew M.
    Murrough, James W.
    Reich, David L.
    Charney, Dennis S.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 220S - 220S
  • [30] Comparative Efficacy of Ketamine in Treatment-Resistant Depression
    Kurt, Hatice Guncu
    Altinay, Murat
    Anand, Amit
    PSYCHIATRIC ANNALS, 2020, 50 (02) : 62 - 67
12345